4//SEC Filing
Kaplan Matthew L. 4
Accession 0001104659-25-107418
CIK 0001875558other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 8:00 AM ET
Size
5.3 KB
Accession
0001104659-25-107418
Insider Transaction Report
Form 4
Kaplan Matthew L.
Director
Transactions
- Purchase
Common Stock
2025-11-05$5.84/sh+11,000$64,240→ 124,760 total
Footnotes (1)
- [F1]Reflects the weighted average purchase price. The range of prices for the shares purchased was $5.81 to $5.88. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
Documents
Issuer
Nuvectis Pharma, Inc.
CIK 0001875558
Entity typeother
Related Parties
1- filerCIK 0001895952
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 8:00 AM ET
- Size
- 5.3 KB